Newsroom

Press Release

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NeoGenomics Reports Second Quarter 2024 Results

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients